Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter

Bastien Gondran-Tellier (1) , Robin Mcmanus (1) , Clement Sichez Pierre (1) , Akram Akiki (1) , Sarah Gaillet (1) , Harry Toledano (2) , Marc Andre (3) , Veronique Delaporte (1) , Vincent Vidal (3, 4) , Gilles Karsenty (1) , Cyrille Bastide (5) , Dominique Rossi (5) , Eric Lechevallier (1) , Romain Boissier (1) , Michael Baboudjian (1)

1 Centre de néphrologie et transplantation rénale [Hôpital de la Conception - APHM]
2 Centre Hospitalier de Martigues
3 Département de Radiologie [Hôpital de la Timone - APHM]
4 LIIE - Laboratoire d'Imagerie Interventionnelle Expérimentale
5 Département d'Urologie [Hôpital Nord - APHM]

Interventional radiology plays an important and increasing role in cancer treatment. Follow-up is important to be able to assess treatment success and detect locoregional and distant recurrence and recommendations for follow-up are needed. At ECIO 2018, a joint ECIO-ESOI session was organized to establish follow-up recommendations for oncologic intervention in liver, renal, and lung cancer. Treatments included thermal ablation, TACE, and TARE. In total five topics were evaluated: ablation in colorectal liver metastases (CRLM), TARE in CRLM, TACE and TARE in HCC, ablation in renal cancer, and ablation in lung cancer. Evaluated modalities were FDG-PET-CT, CT, MRI, and (contrast-enhanced) ultrasound. Prior to the session, five experts were selected and performed a systematic review and presented statements, which were voted on in a telephone conference prior to the meeting by all panelists. These statements were presented and discussed at the ECIO-ESOI session at ECIO 2018. This paper presents the recommendations that followed from these initiatives. Based on expert opinions and the available evidence, follow-up schedules were proposed for liver cancer, renal cancer, and lung cancer. FDG-PET-CT, CT, and MRI are the recommended modalities, but one should beware of false-positive signs of residual tumor or recurrence due to inflammation early after the intervention. There is a need for prospective preferably multicenter studies to validate new techniques and new response criteria. This paper presents recommendations that can be used in clinical practice to perform the follow-up of patients with liver, lung, and renal cancer who were treated with interventional locoregional therapies.

Keywords: Recommendations; Interventional radiology; Oncology; Liver; Lung cancer

Domains: Life Sciences [q-bio]; Urology and Nephrology

Bastien Gondran-Tellier, Robin Mcmanus, Clement Sichez Pierre, Akram Akiki, Sarah Gaillet, et al.. Efficacy and Safety of Surgery for Benign Prostatic Obstruction in Patients with Preoperative Urinary Catheter. Journal of Endourology and Part B, Videourology, 2021, 35 (1), pp.102-108. ⟨10.1089/end.2020.0704⟩. ⟨hal-03165832⟩